Repositório Científico do Instituto Nacional de Saúde >
Departamento de Epidemiologia >
DEP - Artigos em revistas internacionais >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10400.18/700

Título: I-Move towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in europe, 2008-9
Autor: Kissling, E.
Valenciano, M.
Falcao, J.
Larrauri, A.
Widgren, K.
Pitigoi, D.
Oroszi, B.
Nunes, B.
Savulescu, C.
Mazick, A.
Lupulescu, E.
Ciancio, B.
Moren, A.
Palavras-chave: Estados de Saúde e de Doença
Epidemiologia
Influenza
Seasonal Vaccine
Pandemic Influenza Vaccine
Effectiveness
Issue Date: Nov-2009
Editora: European Centre for Disease Prevention and Control
Citação: Euro Surveill. 2009 Nov 5;14(44). pii: 19388
Resumo: Within I-MOVE (European programme to monitor seasonal and pandemic influenza vaccine effectiveness (IVE)) five countries conducted IVE pilot case-control studies in 2008-9. One hundred and sixty sentinel general practitioners (GP) swabbed all elderly consulting for influenza-like illness (ILI). Influenza confirmed cases were compared to influenza negative controls. We conducted a pooled analysis to obtain a summary IVE in the age group of >or=65 years. We measured IVE in each study and assessed heterogeneity between studies qualitatively and using the I2 index. We used a one-stage pooled model with study as a fixed effect. We adjusted estimates for age-group, sex, chronic diseases, smoking, functional status, previous influenza vaccinations and previous hospitalisations. The pooled analysis included 138 cases and 189 test-negative controls. There was no statistical heterogeneity (I2=0) between studies but ILI case definition, previous hospitalisations and functional status were slightly different. The adjusted IVE was 59.1% (95% CI: 15.3-80.3%). IVE was 65.4% (95% CI: 15.6-85.8%) in the 65-74, 59.6% (95% CI: -72.6 -90.6%) in the age group of >or=75 and 56.4% (95% CI: -0.2-81.3%) for A(H3). Pooled analysis is feasible among European studies. The variables definitions need further standardisation. Larger sample sizes are needed to achieve greater precision for subgroup analysis. For 2009-10, I-MOVE will extend the study to obtain early IVE estimates in groups targeted for pandemic H1N1 influenza vaccination.
Arbitragem científica: yes
URI: http://hdl.handle.net/10400.18/700
ISSN: 1560-7917
Versão do Editor: http://www.eurosurveillance.org/viewarticle.aspx?articleid=19388
Appears in Collections:DEP - Artigos em revistas internacionais

Files in This Item:

File Description SizeFormat
“I-MOVE” towards monitoring seasonal and pandemic influenza vaccine effectiveness.pdf310,21 kBAdobe PDFView/Open

Please give feedback about this item
Statistics
FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpaceOrkut
Formato BibTex mendeley Endnote Logotipo do DeGóis 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

  © 2010 www.insa.pt - Todos os direitos reservados | Feedback Ministério da Saúde
Promotores do RCAAP   Financiadores do RCAAP

Fundação para a Ciência e a Tecnologia Universidade do Minho   Governo Português Ministério da Educação e Ciência PO Sociedade do Conhecimento (POSC) Portal oficial da União Europeia